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Presence and role of Simian Virus 40 (SV40) 
in malignant pleural mesothelioma
Julija Hmeljak and Andrej Cör
University of Primorska, College of Health Care Izola, Slovenia 
Background. Evidence of a possible role of viruses in cancer first emerged in the early 1900s and was 
confirmed after the discovery of Epstein-Barr virus (EBV) in Burkitt’s lymphoma cells. Thereafter, several 
oncogenic viruses and retroviruses were characterised. It is estimated that 15% of human malignancies are 
of viral aetiology. Oncogenic viruses use different proteins to interfere dramatically with the cellular cell 
cycle and affect many signalling pathways and checkpoints, causing genomic instability, immunoresistance 
and immortality. 
Conclusions. Simian virus 40 (SV40) is a small DNA virus from the genus polyomavirus, closely related 
to human polyomaviruses John Cunningham virus (JCV) and BK virus (BKV) and is highly oncogenic for 
rodents. The virus accidentally entered the human population through contaminated early batches of polio 
vaccine in the 1960s. After the discovery of SV40-like DNA sequences in mesothelioma samples in 1994, a 
new wave of research started, focusing on the role of SV40 in malignant pleural mesothelioma and human 
cancer in general. Although the virus is not considered a cancer causing agent for humans, it is thought to 
have a (not yet defined) role in the development of the malignancy. Further research to better understand 
the interactions between the virus and the mesothelial cell is still ongoing. 
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Introduction
Evidence of a possible role of viruses in 
cancer first emerged in the early 1900s, 
but because malignancies were considered 
to be non-contagious, the findings were 
received with scepticism. The debate was 
finalised in 1964, when Epstein-Barr virus 
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(EBV) was discovered in Burkitt lymphoma 
malignant cells. Further studies identified 
several other cancer–inducing human vi-
ruses and, in 1990, it was estimated that 
viruses and other infecting agents are as-
sociated with about 15% of all human can-
cer cases worldwide.1 In addition to EBV, 
the most prominent human oncogenic 
DNA viruses are hepatitis B virus (HBV), 
human papilloma virus (HPV) and Kaposi 
sarcoma herpes virus (KSHV). Oncogenic 
retroviruses exist, too, and their role in 
human cancers has been discussed else-
where.3
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Oncogenic viruses dramatically interfere 
with the cell cycle and affect many signal-
ling pathways and checkpoints.2 Different 
viruses use specific products to induce a 
progressive transition to the malignant 
phenotype. They may cause genetic insta-
bility of the infected cell, resistance to the 
immune system and cellular immortality. 
Oncogenic DNA viruses adopt several 
different mechanisms to trigger host cell 
malignant transformation; a common fea-
ture of all oncogenic viruses is the ability to 
use multiple strategies. HPV oncoproteins, 
for example, induce genomic instability by 
inducing centrosome duplication errors and 
formation of abnormal centrioles, leading 
to a dysfunctional mitotic spindle and chro-
mosomal imbalancies in daughter cells and, 
at the same time, prevent apoptosis. KSHV 
and EBV oncoproteins induce cell immor-
talization by modulating telomerase activity 
and promoting the alternative lengthening 
of telomeres (ALT) pathway. These mecha-
nisms help cells bypass crisis and grant a 
dramatically prolonged lifespan. Other viral 
proteins destabilize p53, allowing cells to ig-
nore cell cycle checkpoints and undergo un-
disturbed proliferation. Viral proteins inter-
fere with the cellular microenvironment and 
impair communication with adjacent cells, 
ensuring a stable malignant phenotype and 
invasiveness of the host cell.1
Other DNA viruses can cause malignant 
transformations in vitro, but their definite 
role in human cancer is not determined. 
This group includes several adenoviruses 
and polyomaviruses. Very recently, a new 
polyomavirus has been identified and iso-
lated from human Merkel cell carcinoma 
and could be the main causative agent for 
this skin malignancy.3 Another polyomavi-
rus, Simian virus 40 (SV40), is being exten-
sively studied for its possible role as a hu-
man carcinogen, since it is highly oncogen-
ic for rodents. The virus can also transform 
human cells in vitro and the first successful 
attempt to convert normal human cells to 
a stable malignant phenotype with a de-
fined set of genetic elements actually used 
a combination of SV40, hRAS and hTERT 
sequences.4
SV40 in cancer
SV40, also known as Simian vacuolating 
virus 40, is a small (approximately 40 nm in 
diameter) icosahedral non-enveloped DNA 
virus from the genus polyomavirus (Figure 
1). It is closely related to, and shares approx-
imately 70% sequence similarity with, the 
human polyomaviruses John Cunningham 
virus (JCV) and BK virus (BKV; named 
after the initials B.K. of a renal transplant 
patient; viral particles were found in his 
urine). Its genome consists of a single cir-
cular double stranded DNA molecule and 
can be divided into three distinct regions 
– early, late and regulatory. The early region 
is expressed soon after entrance into the 
host cell, while the late region is expressed 
efficiently only after successful viral DNA 
replication has begun and it encodes for 
the capsid proteins (Figure 2).5 
Figure 1. Transmission electron micrograph of 
polyomavirus SV40 (photo by Dr. E. Palmer, Center 
for Disease Control (CDC), GA, USA; no copyright 
restrictions under Public Domain – Property of the 
United States federal government (PD-USGov)).
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Its primary hosts are rhesus macaque 
(Macaca mulatta) monkeys. The virus is ca-
pable of causing tumours when injected 
into rodents.6 Low antibody titters in hu-
man sera show that, compared to monkeys, 
replication of SV40 in humans is inefficient 
and that the virus is poorly adapted to the 
alternative host.5 
Since the accidental contamination of 
large early batches of polio vaccine in the 
1950s and 1960s, the previously unknown 
virus has spread in the human population 
and has become seen as an emerging human 
pathogen.7 Both oral and intravenous vac-
cines were initially produced using rhesus 
monkey primary cell lines, some of which 
were naturally contaminated with SV40. 
The virus was discovered several years af-
ter the start of the mass polio immuniza-
tion programme.8 An unknown proportion 
of the vaccine was contaminated, presum-
ably with small amounts of SV40.9 The 
number of patients given the contaminated 
vaccine is also unknown, but estimates ex-
ist of more than 98 million people exposed 
to the contaminated vaccine in the United 
States alone.10 Batches of intravenous po-
lio vaccine (IPV – intravenous inactivated 
(Salk’s) polio vaccine) produced after 1963 
were SV40-free, while the virus remained 
present in the oral vaccine (OPV − oral 
live attenuated (Sabin's) polio vaccine) un-
til the 1970s. Contaminated OPV and IPV 
were inadvertently used in many countries 
other than the United States, including the 
former Soviet Union, Japan, the United 
Kingdom, Italy, Mexico and several Central 
American and European countries.5 No of-
ficial records are available for Slovenia, but 
it is thought that no contaminated vaccine 
was used. It is presumed that SV40 has a 
tumour inducing or promoting role in hu-
mans.10 Possible effects on human health, 
including the development of cancer, have 
been extensively researched in the past 
fifty years and many studies are still ongo-
ing.
The virus triggers malignant transfor-
mations of both animal and human cells 
in vitro and is oncogenic for rodents when 
injected intraperitoneally or pericardially. 
Malignant transformation occurs if SV40 
DNA becomes integrated in the host cell 
genome or remains in stable episomal form 
in the cytosol.5 In mice, latent infection 
with SV40 can cause malignancy, mediated 
by two early viral proteins: large T antigen 
(Tag) and small t antigen (tag). Labelled 
one of the most potent oncogenic proteins, 
Tag has multiple functions in the host cell. 
It mainly acts as a transcriptional suppres-
sor of tumour suppressor genes, while tag 
inhibits protein phosphatase 2A and thus 
serves as a modulator of Tag. Other im-
portant roles of Tag are direct binding and 
inactivation of expressed p53 and Rb and 
induction of insuline-like growth factor-1 
(I-LGF 1) and its receptor11 and, as recently 
discovered, p53-Tag complexes act as tran-
scription factors acting as an inductor of I-
LGF 1 promoter.12 
Figure 2. Structural view of the 5243 nucleotide SV40 
genome with its characteristic nucleosomes. Blue 
highlights the early region, while the late region is 
green. Yellow and red denote the regulatory region of 
the viral genome (modified from D.S. Goodsell. Simian 
Virus 40 – November 2003 Molecule of the Month. 
Research Collaboratory for Structural Bioinformatics 
(RCSB) Protein Data Bank; no copyright restrictions 
under PD-USGov).
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Large T antigen alone can initiate and 
maintain malignancy in hamster cells, but it 
is presumed that other events on the cellular 
level are required for in vitro malignant trans-
formation of human cells.13 Experimental 
data has shown that co-expression of SV40 
early genes (Tag and tag genes), telomerase 
activity and oncogenic hRAS are sufficient 
for stable malignant transformation of hu-
man cells in vitro. This is mediated by per-
turbation of several intracellular signalling 
and metabolic pathways.5 
The possible role of SV40 in human ma-
lignancies has been intensively debated. It 
is presumed that SV40 has either a tumour 
inducing or promoting role in humans.10 
Some human tumours (bone sarcomas, 
non-Hodgkin’s lymphomas, brain tumours 
and mesothelioma in particular) frequently 
contain proviral DNA, usually in episomal 
form. 
The strongest association between SV40 
and human malignancies has been shown 
for malignant pleural mesothelioma.14
SV40 in malignant mesothelioma
Malignant pleural mesothelioma (MPM) is a 
rare but highly invasive tumour that is very 
rarely curable.15,16 It arises from the malig-
nant transformation of mesothelial cells, a 
uniform layer of non-differentiated serosal 
epithelial cells lining the pleura, the perito-
neum and the pericardium (Figure 3).11,15 
Among mesothelial malignancies, MPM 
is the most common, accounting for about 
90% of all mesothelioma cases. It causes on 
average one death per million inhabitants 
worldwide, with very significant geographi-
cal variability,16,17 since the incidence in 
Europe and Australia is considerably higher 
than in the Americas.18
There is no doubt that the vast majority 
of MPM are caused by asbestos fibres, since 
only 20% of mesothelioma cases occur with-
out previous exposure to asbestos.14,16 The 
data of patients with mesothelioma who 
had not been exposed to asbestos has var-
ied.15,19 
However, since only a small fraction of 
subjects exposed to asbestos fibres develop 
MPM, it has been suggested that addition-
al factors may be involved in mesothelial 
malignant transformations. Other causes, 
in addition to asbestos, including non-
asbestos fibres (erionite, in Cappadocia, 
Turkey), therapeutic radiation and intense 
pleural scarring (caused by prior plombage 
therapy for tuberculosis) have been report-
ed to cause mesothelioma in rare cases.18 
Detection of Simian virus 40 DNA in sev-
eral MPM tissue samples suggests that the 
virus itself could be the factor that renders 
some asbestos exposed individuals more 
susceptible to MPM.20 
The discovery of SV40-like sequences 
in the genome of several MPM patients by 
Carbone et al.21 in 1994 caused much con-
troversy. Several studies of the presence of 
specific anti SV40 antibodies in patients’ 
sera were mostly negative or detected ex-
tremely low antibody levels. Engels et al.22 
stated that these results mean that the anti-
body titter declined over the years, probably 
due to a lack of virus replication, indicating 
Figure 3. Classic HE stain of malignant pleural 
mesothelioma.
Hmeljak J and Cör A / SV40 in malignant pleural mesothelioma 13
Radiol Oncol 2009; 43(1): 9-16.
a latent infection. Only the discovery of vi-
ral proteins within tumour tissues has con-
firmed the actual presence of the virus.23 
Traces of either viral DNA or proteins 
have been repeatedly found in various inde-
pendent studies. It is now accepted that me-
sothelial cells are unusually susceptible to 
SV40 mediated transformation,5 but there is 
no indisputable epidemiological proof that 
contamination with SV40 increases the risk 
of developing MPM or cancer mortality.10 
In vitro testing has shown that SV40 in-
fects only about 20% of human fibroblasts 
and epithelial cells and becomes integrated 
in the cellular genome in only a small frac-
tion (1/107) of infected cells. This results in 
cell lysis and thus prevents malignant trans-
formation. Mesothelial cells, on the other 
hand, behave very differently compared to 
fibroblasts and epithelial cells. They seem 
to be more permissive for SV40 infection, 
but about 80% of infected mesothelial cells 
survive infection and undergo latent, rather 
than lytic, infection. Infected mesothelial 
cells actively express Tag, but do not pro-
duce viral particles. A very high rate, ap-
proximately 1/103 cells, undergo malignant 
transformation.11 
One of the easiest and most sensitive 
techniques for SV40 DNA detection in tis-
sue and cell culture samples is polymerase 
chain reaction (PCR). The vast majority of 
researchers who have published scientific 
papers on the presence of SV40 in mesothe-
lioma have used this technique. However, 
wide discordance in the results, poor repro-
ducibility and episodes of positive results 
in no-template negative controls, has led 
to a questioning of the specificity and sen-
sitivity of PCR assays.11 Other viral detec-
tion techniques, such as Southern blotting, 
DNA sequencing, mRNA in situ hybridiza-
tion, Tag immunoprecipitation, electron 
microscopy, immunohistochemistry and 
immunofluorescence, have been used to 
confirm the positiveness of PCR results.5 
It is surprising that immunostaining of 
Tag in tissue samples revealed that viral ex-
pression is present in MPM cells, but not 
in the adjacent stromal and lung tissue.11 
This observation, together with low viral 
DNA copy numbers and the virtual ab-
sence of anti-SV40 antibodies in patients’ 
sera, suggests that SV40 might be the fac-
tor that initiates carcinogenesis and be-
comes redundant and lost at a later stage, 
allowing the cancerous cells to evade the 
immune response, survive and grow.5 This 
behaviour is consistent with the »hit and 
run« hypothesis in viral carcinogenesis. 
According to this hypothesis, infected cells 
evade the innate immune system response 
in early phases of viral infection and ma-
lignant transformation. In later phases, the 
cells become stably malignant and some 
lose the viral genome before specific anti-
bodies are formed. Malignant cells that do 
not express viral proteins are less immuno-
genic, which gives them a selective advan-
tage compared to malignant cells with an 
active viral infection. There are no conclu-
sive data on its credibility yet, but the »hit 
and run« hypothesis is a possible explana-
tion for the lack of specific antibodies in 
the sera of patients with putative virus-as-
sociated cancers.1
Asbestos and SV40 co-carcinogenity
Recent studies have shown a strong co-
carcinogenic effect of crocidolite asbestos 
fibres and SV40 on hamster and human 
mesothelial cells. Asbestos exposure com-
plements SV40 infected cells in malignant 
transformation.11 Moreover, the same effect 
has been observed and extensively studied 
in experimental animals.20 Human mes-
othelial cells are particularly sensitive to 
both asbestos genotoxicity and SV40 trans-
formation. It is assumed that the latter may 
have the pivotal malignancy inducing role 
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in the mesothelium, especially in cells with 
asbestos damaged DNA.24 
Asbestos fibres easily penetrate inside a 
cell, where they induce extensive DNA dam-
age. The fibres generate genotoxic reactive 
oxygen and nitrogen species, cathalyse the 
synthesis of nitrotyrosine and induce DNA 
strand breaks. The presence of SV40 in as-
bestos exposed mesothelial cells affects the 
cell cycle, DNA repair and signalling path-
ways, especially through the interaction of 
some viral proteins (Tag and tag) with p53. 
The strong affinity of Tag for binding and 
inactivating p53 results in the cell avoiding 
key cell cycle checkpoints, thus surviving 
the otherwise fatal DNA damage and un-
dergoing mitosis.24,25 By escaping apopto-
sis and surviving, asbestos-damaged SV40 
infected mesothelial cells pave the way to 
malignant transformation. It is very likely 
that asbestos fibres and viral Tag and tag 
interact and synergistically activate cellular 
signalling pathways, especially the ERK/
AP-1 pathway, that lead to cell proliferation, 
malignant transformation and invasion.20
Conclusions and future aspects
Dilemmas and controversies about the role 
of SV40 as a human carcinogen are still 
strong, despite the ongoing extensive re-
search. There is no powerful evidence of 
the exact role of SV40 in human cancers 
and MPM in particular. Some studies have 
suggested that the virus does not have a 
major implication in the development of 
MPM,9,24 but several others claim the op-
posite.20 
Researchers are still not able to find con-
sensus, mainly because of flaws attributed 
to different SV40 detection techniques. The 
lack of appropriate, standardized approach-
es and quality control measures further adds 
to the controversy.26 There is a high risk of 
false positive results, especially when using 
sensitive DNA detection techniques such 
as PCR. Some recent studies have proved 
that many previously published results of 
SV40 positive tumour specimens were not 
reproducible. The authors suggested con-
tamination with laboratory plasmids and, 
for serological assays, cross-reactivity with 
antibodies to the SV40-related human poly-
omaviruses BKV and JCV.9 The viral DNA 
sequences are common in many engineered 
plasmids and several immortalized cell 
lines, including the extensively used Wi-38 
(ATCC acc. no. CCL-75.1). SV40 sequences 
containing DNA from these sources can 
easily contaminate PCR reaction mixes and 
laboratory equipment. 
Figure 4. Amplification curve 
of a quantitative (real-time) 
polymerase chain reaction 
(qPCR) assay performed on 
DNA from mesothelioma tissue 
samples and DNA from SV40-
transformed Wi-38 cells (ATCC 
acc. no. CCL-75.1) using a prim-
er set for SV40 large T antigen 
(SV.for3 and SV.rev primers)27 
and two custom-made primer 
sets for SV40 small t antigen. 
Positive results were obtained 
only for the Wi-38 derived 
DNA, while mesothelioma sam-
ples were SV40 free.
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Extremely careful experiment design for 
every single step in the process is thus a 
must for reliable results, especially to avoid 
sample contamination and cross-contami-
nation. Choosing multiple and appropriate 
primer sets for PCR can also avoid false-
positive results and increase reproducibil-
ity (Figure 4). 
Better understanding of viral carcinogen-
esis in general could provide new insights 
in our understanding of cancer biology and 
treatment.1 Further studies, aimed not only 
at confirming the presence of the virus, but 
also at elucidating its role, will provide an-
swers to open questions about a possible 
causal link.
Ongoing extensive research on the topic 
proves that elucidating the link between 
SV40 and MPM is of major interest to the 
scientific community. What seemed like a 
complex jigsaw puzzle even a few years ago 
is now being assembled and clarified and 
we will probably be able to tell the whole 
story very soon. 
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